2015 annual financial data
Alnylam Pharmaceuticals 2015 Net margin
Direct answer
Net margin was -705.83%.
Operating income was -296.01M USD and net income was -290.07M USD.
Operating cash flow was -189.14M USD.
Get free Alnylam Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 41.1M USD
- Operating income
- -296.01M USD
- Net income
- -290.07M USD
- Operating cash flow
- -189.14M USD
Explore related company data
View all 2015 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Alnylam Pharmaceuticals financial years